Paid Clinical Trials Jersey City
Discover 1,038 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Tirzepatide & IxekizumabA Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06857942
Conditions
Psoriasis
Overweight or Obesity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tirzepatide
AmlitelimabA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
Sponsor:
Sanofi
Location:
Code:
NCT06181435
Conditions
Dermatitis Atopic
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Amlitelimab
Placebo
Tobacco TrainingPediatric Residency Training On Tobacco
Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Location:
Code:
NCT00098215
Conditions
Tobacco Use Disorder
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Accepted
Interventions
Pediatric residency training on tobacco
StatinsStatins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Sponsor:
Rutgers, The State University of New Jersey
Location:
Code:
NCT05559164
Conditions
Cardiac Toxicity
Early-stage Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lipitor 40mg Tablet
Liposomal Doxorubicin & CarboplatinOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
Sponsor:
Mridula George, MD
Location:
Code:
NCT05949021
Conditions
Triple Negative Breast Cancer (TNBC)
Eligibility Criteria
Sex: Female
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Combination of liposomal doxorubicin
ANG-3070Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease
Sponsor:
Angion Biomedica Corp
Location:
Code:
NCT04939116
Conditions
Glomerular Disease
Proteinuria
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ANG-3070
Placebo
Observational StudyInnovations in Genicular Outcomes Registry
Sponsor:
Pacira Pharmaceuticals, Inc
Location:
Code:
NCT05495334
Conditions
Knee Osteoarthritis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Treatment for Knee OA
Genomic AnalysisTargeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Sponsor:
Rutgers, The State University of New Jersey
Location:
Code:
NCT02688517
Conditions
Malignant Neoplasm
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Interventions
Cytology Specimen Collection Procedure
Laboratory Biomarker Analysis
Radiation TherapyRadiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer
Sponsor:
Rutgers, The State University of New Jersey
Location:
Code:
NCT04871516
Conditions
Anatomic Stage 0 Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Quality-of-Life Assessment
Questionnaire Administration
Radiation Boost
Therapeutic Surgical Procedure
Whole Breast Irradiation
SalbutamolA Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT06261957
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Salbutamol HFA-134a
Salbutamol HFA-152a